Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan
Sign Up to like & getrecommendations! Published in 2018 at "Cardiovascular Intervention and Therapeutics"
DOI: 10.1007/s12928-018-0515-z
Abstract: The Cobalt Chromium Everolimus-Eluting Stent (CoCr-EES) Post Marketing Surveillance (PMS) Japan study is a prospective multicenter registry designed to evaluate the safety and efficacy of XIENCE V/PROMUS everolimus-eluting stents in routine clinical practice at 47… read more here.
Keywords: cocr ees; clinical outcomes; year; japan ... See more keywords
Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
Sign Up to like & getrecommendations! Published in 2017 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000000518
Abstract: Background Everolimus-eluting bioresorbable vascular scaffold (BVS) (Absorb BVS; Abbott Vascular, Santa Clara, California, USA) technology emerged with the promise that late stent-related coronary events could be prevented and coronary artery vasomotion could be restored, returning… read more here.
Keywords: cocr ees; scaffold thrombosis; bioresorbable vascular; thrombosis ... See more keywords